Pesquisa | BVS Violência e Saúde

1.

Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.

Handunnetti, Sasanka M; Anderson, Mary Ann; Burbury, Kate I; Thompson, Philip A; Burke, Glenda; Bressel, Mathias; Di Iulio, Juliana L; Hicks, Rodney John; Westerman, David A; Lade, Stephen; Pott, Christiane; Agarwal, Rishu; Koldej, Rachel M; Ritchie, David; Dreyling, Martin; Dawson, Mark A; Dawson, Sarah-Jane; Seymour, John F; Roberts, Andrew W; Tam, Constantine S.

Blood ; 2024 Apr 25.

Artigo em Inglês | MEDLINE | ID: mdl-38662991

2.

Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disorders.

Thompson, Philip A; Tam, Constantine S.

Blood ; 141(26): 3137-3142, 2023 06 29.

Artigo em Inglês | MEDLINE | ID: mdl-37156004

3.

Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up.

Thompson, Philip A; Bazinet, Alexandre; Wierda, William G; Tam, Constantine S; O'Brien, Susan M; Saha, Satabdi; Peterson, Christine B; Plunkett, William; Keating, Michael J.

Blood ; 142(21): 1784-1788, 2023 11 23.

Artigo em Inglês | MEDLINE | ID: mdl-37595283

4.

Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.

Davids, Matthew S; Rogers, Kerry A; Tyekucheva, Svitlana; Wang, Zixu; Pazienza, Samantha; Renner, Sarah K; Montegaard, Josie; Ihuoma, Udochukwu; Lehmberg, Timothy Z; Parry, Erin M; Wu, Catherine J; Jacobson, Caron A; Fisher, David C; Thompson, Philip A; Brown, Jennifer R.

Blood ; 139(5): 686-689, 2022 02 03.

Artigo em Inglês | MEDLINE | ID: mdl-34788401

5.

Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors.

Sasaki, Koji; Kantarjian, Hagop M; Short, Nicholas J; Samra, Bachar; Khoury, Joseph D; Kanagal Shamanna, Rashmi; Konopleva, Marina; Jain, Nitin; DiNardo, Courtney D; Khouri, Rita; Garcia-Manero, Guillermo; Kadia, Tapan M; Wierda, William G; Khouri, Issa F; Kebriaei, Partow; Mehta, Rohtesh S; Champlin, Richard E; Garris, Rebecca; Cheung, Cora Marie; Daver, Naval; Thompson, Philip A; Yilmaz, Musa; Ravandi, Farhad; Jabbour, Elias.

Cancer ; 127(15): 2648-2656, 2021 08 01.

Artigo em Inglês | MEDLINE | ID: mdl-33793964

6.

Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy.

Thompson, Philip A; Srivastava, Jaya; Peterson, Christine; Strati, Paolo; Jorgensen, Jeffrey L; Hether, Tyler; Keating, Michael J; O'Brien, Susan M; Ferrajoli, Alessandra; Burger, Jan A; Estrov, Zeev; Jain, Nitin; Wierda, William G.

Blood ; 134(22): 1951-1959, 2019 11 28.

Artigo em Inglês | MEDLINE | ID: mdl-31537528

7.

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia.

Rogers, Kerry A; Thompson, Philip A; Allan, John N; Coleman, Morton; Sharman, Jeff P; Cheson, Bruce D; Jones, Daniel; Izumi, Raquel; Frigault, Melanie M; Quah, Cheng; Raman, Rakesh K; Patel, Priti; Wang, Min Hui; Kipps, Thomas J.

Haematologica ; 106(9): 2364-2373, 2021 09 01.

Artigo em Inglês | MEDLINE | ID: mdl-33730844

8.

Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality.

Maiti, Abhishek; Qiao, Wei; Sasaki, Koji; Ravandi, Farhad; Kadia, Tapan M; Jabbour, Elias J; Daver, Naval G; Borthakur, Gautam; Garcia-Manero, Guillermo; Pierce, Sherry A; Montalbano, Kathryn S; Pemmaraju, Naveen; Naqvi, Kiran; Ohanian, Maro; Short, Nicholas J; Alvarado, Yesid; Takahashi, Koichi; Yilmaz, Musa; Jain, Nitin; Kornblau, Steven M; Andreeff, Michael; Bose, Prithviraj; Ferrajoli, Alessandra; Issa, Ghayas C; Masarova, Lucia; Thompson, Philip A; Rausch, Caitlin R; Ning, Jing; Kantarjian, Hagop M; DiNardo, Courtney D; Konopleva, Marina Y.

Am J Hematol ; 96(3): 282-291, 2021 03 01.

Artigo em Inglês | MEDLINE | ID: mdl-33264443

9.

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.

Chen, Lisa S; Bose, Prithviraj; Cruz, Nichole D; Jiang, Yongying; Wu, Qi; Thompson, Philip A; Feng, Shuju; Kroll, Michael H; Qiao, Wei; Huang, Xuelin; Jain, Nitin; Wierda, William G; Keating, Michael J; Gandhi, Varsha.

Blood ; 132(21): 2249-2259, 2018 11 22.

Artigo em Inglês | MEDLINE | ID: mdl-30254130

10.

The involvement of microRNA in the pathogenesis of Richter syndrome.

Van Roosbroeck, Katrien; Bayraktar, Recep; Calin, Steliana; Bloehdorn, Johannes; Dragomir, Mihnea Paul; Okubo, Keishi; Bertilaccio, Maria Teresa Sabrina; Zupo, Simonetta; You, M James; Gaidano, Gianluca; Rossi, Davide; Chen, Shih-Shih; Chiorazzi, Nicholas; Thompson, Philip A; Ferrajoli, Alessandra; Bertoni, Francesco; Stilgenbauer, Stephan; Keating, Michael J; Calin, George A.

Haematologica ; 104(5): 1004-1015, 2019 05.

Artigo em Inglês | MEDLINE | ID: mdl-30409799

11.

The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.

Jain, Preetesh; Nogueras González, Graciela M; Kanagal-Shamanna, Rashmi; Rozovski, Uri; Sarwari, Nawid; Tam, Constantine; Wierda, William G; Thompson, Philip A; Jain, Nitin; Luthra, Rajyalakshmi; Quesada, Andres; Sanchez-Petitto, Gabriela; Ferrajoli, Alessandra; Burger, Jan; Kantarjian, Hagop; Cortes, Jorge; O'Brien, Susan; Keating, Michael J; Estrov, Zeev.

Br J Haematol ; 180(1): 33-40, 2018 01.

Artigo em Inglês | MEDLINE | ID: mdl-29164608

12.

Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL.

Thompson, Philip A; Wierda, William G.

Blood ; 127(3): 279-86, 2016 Jan 21.

Artigo em Inglês | MEDLINE | ID: mdl-26576865

13.

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.

Thompson, Philip A; Tam, Constantine S; O'Brien, Susan M; Wierda, William G; Stingo, Francesco; Plunkett, William; Smith, Susan C; Kantarjian, Hagop M; Freireich, Emil J; Keating, Michael J.

Blood ; 127(3): 303-9, 2016 Jan 21.

Artigo em Inglês | MEDLINE | ID: mdl-26492934

14.

Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.

Khan, Maliha; Siddiqi, Rabbia; Thompson, Philip A.

Ann Hematol ; 97(1): 1-15, 2018 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-29063177

15.

Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.

Jabbour, Elias; Düll, Johannes; Yilmaz, Musa; Khoury, Joseph D; Ravandi, Farhad; Jain, Nitin; Einsele, Hermann; Garcia-Manero, Guillermo; Konopleva, Marina; Short, Nicholas J; Thompson, Philip A; Wierda, William; Daver, Naval; Cortes, Jorge; O'brien, Susan; Kantarjian, Hagop; Topp, Max S.

Am J Hematol ; 93(3): 371-374, 2018 03.

Artigo em Inglês | MEDLINE | ID: mdl-29178361

16.

Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib.

Jain, Preetesh; Thompson, Philip A; Keating, Michael; Estrov, Zeev; Ferrajoli, Alessandra; Jain, Nitin; Kantarjian, Hagop; Burger, Jan A; O'Brien, Susan; Wierda, William G.

Cancer ; 123(12): 2268-2273, 2017 Jun 15.

Artigo em Inglês | MEDLINE | ID: mdl-28171709

17.

How I manage patients with hairy cell leukaemia.

Thompson, Philip A; Ravandi, Farhad.

Br J Haematol ; 177(4): 543-556, 2017 05.

Artigo em Inglês | MEDLINE | ID: mdl-28146266

18.

Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.

Thompson, Philip A; Stingo, Francesco; Keating, Michael J; Wierda, William G; O'Brien, Susan M; Estrov, Zeev; Ledesma, Celina; Rezvani, Katayoun; Qazilbash, Muzaffar; Shah, Nina; Parmar, Simrit; Popat, Uday; Anderlini, Paolo; Yago, Nieto; Ciurea, Stefan O; Kebriaei, Partow; Champlin, Richard; Shpall, Elizabeth J; Hosing, Chitra M.

Br J Haematol ; 177(4): 567-577, 2017 05.

Artigo em Inglês | MEDLINE | ID: mdl-28295181

19.

Occupy BTK: the key to controlling CLL.

Thompson, Philip A.

Blood ; 136(1): 4-6, 2020 07 02.

Artigo em Inglês | MEDLINE | ID: mdl-32614961

20.

Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors.

Strati, Paolo; Schlette, Ellen J; Solis Soto, Luisa M; Duenas, Daniela E; Sivina, Mariela; Kim, Ekaterina; Keating, Michael J; Wierda, William G; Ferrajoli, Alessandra; Kantarjian, Hagop; Estrov, Zeev; Jain, Nitin; Thompson, Philip A; Wistuba, Ignacio I; Burger, Jan A.

Blood ; 135(7): 510-513, 2020 02 13.

Artigo em Inglês | MEDLINE | ID: mdl-31895947

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: